Morgan Stanley Knock-Out RVTY/ DE000ME42JU3 /
| 15.11.2024 21:15:37 | Изменение-0.65 | Бид22:00:35 | Предложение22:00:35 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
|---|---|---|---|---|---|---|---|
| 1.60EUR | -28.89% | - Величина цены спроса: - |
- Величина цены предложения: - |
Revvity Inc | 93.4696 USD | 31.12.2078 | Call |
GlobeNewswire
07.08
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress
GlobeNewswire
20.06
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
GlobeNewswire
03.06
Orion is developing the Finnish life science industry in a unique collaboration project
GlobeNewswire
28.05
Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Grea...
GlobeNewswire
09.05
Curia and Carterra Partner on Biologics Symposium to Further Biotechnology Research in the Pacific N...
GlobeNewswire
19.01
Bionano Announces the Final Speaker Lineup for 2024 Symposium with 33 OGM Presentations and Live Pan...
GlobeNewswire
08.01
Pleno Deploys its RAPTOR Instrument Platform Available with TotalSeq™ Antibodies from BioLegend
GlobeNewswire
30.11.2023
Study Shows that OGM Plays an Important Role in Efficient Diagnosis of FSHD
GlobeNewswire
13.11.2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. -...
GlobeNewswire
05.11.2023
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Revvity, Inc. - ...
GlobeNewswire
18.05.2021
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study...
GlobeNewswire
11.05.2021
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunol...
GlobeNewswire
29.04.2021
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell R...
